199 related articles for article (PubMed ID: 30443171)
1. NDRG1 Downregulates ATF3 and Inhibits Cisplatin-Induced Cytotoxicity in Lung Cancer A549 Cells.
Du A; Jiang Y; Fan C
Int J Med Sci; 2018; 15(13):1502-1507. PubMed ID: 30443171
[TBL] [Abstract][Full Text] [Related]
2. The metastasis suppressor, N-myc downstream regulated gene 1 (NDRG1), upregulates p21 via p53-independent mechanisms.
Kovacevic Z; Sivagurunathan S; Mangs H; Chikhani S; Zhang D; Richardson DR
Carcinogenesis; 2011 May; 32(5):732-40. PubMed ID: 21398495
[TBL] [Abstract][Full Text] [Related]
3. KAI1 gene is engaged in NDRG1 gene-mediated metastasis suppression through the ATF3-NFkappaB complex in human prostate cancer.
Liu W; Iiizumi-Gairani M; Okuda H; Kobayashi A; Watabe M; Pai SK; Pandey PR; Xing F; Fukuda K; Modur V; Hirota S; Suzuki K; Chiba T; Endo M; Sugai T; Watabe K
J Biol Chem; 2011 May; 286(21):18949-59. PubMed ID: 21454613
[TBL] [Abstract][Full Text] [Related]
4. NDRG1 disruption alleviates cisplatin/sodium glycididazole-induced DNA damage response and apoptosis in ERCC1-defective lung cancer cells.
He L; Liu K; Wang X; Chen H; Zhou J; Wu X; Liu T; Yang Y; Yang X; Cui D; Song G; Wang J; Lei J
Int J Biochem Cell Biol; 2018 Jul; 100():54-60. PubMed ID: 29768183
[TBL] [Abstract][Full Text] [Related]
5. N-myc downstream regulated gene 1(NDRG1) promotes the stem-like properties of lung cancer cells through stabilized c-Myc.
Wang Y; Zhou Y; Tao F; Chai S; Xu X; Yang Y; Yang Y; Xu H; Wang K
Cancer Lett; 2017 Aug; 401():53-62. PubMed ID: 28456659
[TBL] [Abstract][Full Text] [Related]
6. p53-dependent NDRG1 expression induces inhibition of intestinal epithelial cell proliferation but not apoptosis after polyamine depletion.
Zhang AH; Rao JN; Zou T; Liu L; Marasa BS; Xiao L; Chen J; Turner DJ; Wang JY
Am J Physiol Cell Physiol; 2007 Jul; 293(1):C379-89. PubMed ID: 17442733
[TBL] [Abstract][Full Text] [Related]
7. Induction of Activating Transcription Factor 3 Is Associated with Cisplatin Responsiveness in Non-Small Cell Lung Carcinoma Cells.
Bar J; Hasim MS; Baghai T; Niknejad N; Perkins TJ; Stewart DJ; Sekhon HS; Villeneuve PJ; Dimitroulakos J
Neoplasia; 2016 Sep; 18(9):525-35. PubMed ID: 27659012
[TBL] [Abstract][Full Text] [Related]
8. NDRG1/Cap43/Drg-1 may predict tumor angiogenesis and poor outcome in patients with lung cancer.
Azuma K; Kawahara A; Hattori S; Taira T; Tsurutani J; Watari K; Shibata T; Murakami Y; Takamori S; Ono M; Izumi H; Kage M; Yanagawa T; Nakagawa K; Hoshino T; Kuwano M
J Thorac Oncol; 2012 May; 7(5):779-89. PubMed ID: 22481237
[TBL] [Abstract][Full Text] [Related]
9. Role of GLI1 and NDRG1 in Increased Resistance to Apoptosis Induction.
Wu F; Rom WN; Koshiji M; Mo Y; Hosomi Y; Tchou-Wong KM
J Environ Pathol Toxicol Oncol; 2015; 34(3):213-25. PubMed ID: 26349604
[TBL] [Abstract][Full Text] [Related]
10. Cholesterol and phytosterols differentially regulate the expression of caveolin 1 and a downstream prostate cell growth-suppressor gene.
Ifere GO; Equan A; Gordon K; Nagappan P; Igietseme JU; Ananaba GA
Cancer Epidemiol; 2010 Aug; 34(4):461-71. PubMed ID: 20466611
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of N-myc downstream-regulated gene 1 inhibits human glioma proliferation and invasion via phosphoinositide 3-kinase/AKT pathways.
Ma W; Na M; Tang C; Wang H; Lin Z
Mol Med Rep; 2015 Jul; 12(1):1050-8. PubMed ID: 25777142
[TBL] [Abstract][Full Text] [Related]
12. The activating transcription factor 3 protein suppresses the oncogenic function of mutant p53 proteins.
Wei S; Wang H; Lu C; Malmut S; Zhang J; Ren S; Yu G; Wang W; Tang DD; Yan C
J Biol Chem; 2014 Mar; 289(13):8947-59. PubMed ID: 24554706
[TBL] [Abstract][Full Text] [Related]
13. N-myc downstream regulated gene-1 expression correlates with reduced pancreatic cancer growth and increased apoptosis in vitro and in vivo.
Angst E; Dawson DW; Stroka D; Gloor B; Park J; Candinas D; Reber HA; Hines OJ; Eibl G
Surgery; 2011 May; 149(5):614-24. PubMed ID: 21236457
[TBL] [Abstract][Full Text] [Related]
14. Correlation of N-myc downstream-regulated gene 1 expression with clinical outcomes of colorectal cancer patients of different race/ethnicity.
Koshiji M; Kumamoto K; Morimura K; Utsumi Y; Aizawa M; Hoshino M; Ohki S; Takenoshita S; Costa M; Commes T; Piquemal D; Harris CC; Tchou-Wong KM
World J Gastroenterol; 2007 May; 13(20):2803-10. PubMed ID: 17569115
[TBL] [Abstract][Full Text] [Related]
15. Cisplatin induces cytotoxicity through the mitogen-activated protein kinase pathways and activating transcription factor 3.
St Germain C; Niknejad N; Ma L; Garbuio K; Hai T; Dimitroulakos J
Neoplasia; 2010 Jul; 12(7):527-38. PubMed ID: 20651982
[TBL] [Abstract][Full Text] [Related]
16. p53-independent Noxa induction by cisplatin is regulated by ATF3/ATF4 in head and neck squamous cell carcinoma cells.
Sharma K; Vu TT; Cook W; Naseri M; Zhan K; Nakajima W; Harada H
Mol Oncol; 2018 Jun; 12(6):788-798. PubMed ID: 29352505
[TBL] [Abstract][Full Text] [Related]
17. N-myc downstream-regulated gene 1 promotes oxaliplatin-triggered apoptosis in colorectal cancer cells via enhancing the ubiquitination of Bcl-2.
Yang X; Zhu F; Yu C; Lu J; Zhang L; Lv Y; Sun J; Zheng M
Oncotarget; 2017 Jul; 8(29):47709-47724. PubMed ID: 28537875
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of cisplatin cytotoxicity by disulfiram involves activating transcription factor 3.
O'Brien A; Barber JE; Reid S; Niknejad N; Dimitroulakos J
Anticancer Res; 2012 Jul; 32(7):2679-88. PubMed ID: 22753726
[TBL] [Abstract][Full Text] [Related]
19. The 3p21.3 tumor suppressor RBM5 resensitizes cisplatin-resistant human non-small cell lung cancer cells to cisplatin.
Li P; Wang K; Zhang J; Zhao L; Liang H; Shao C; Sutherland LC
Cancer Epidemiol; 2012 Oct; 36(5):481-9. PubMed ID: 22609235
[TBL] [Abstract][Full Text] [Related]
20. HIF-1α up-regulates NDRG1 expression through binding to NDRG1 promoter, leading to proliferation of lung cancer A549 cells.
Wang Q; Li LH; Gao GD; Wang G; Qu L; Li JG; Wang CM
Mol Biol Rep; 2013 May; 40(5):3723-9. PubMed ID: 23526365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]